Company News

Ituran (ITRN) Q4 EPS Jumps 10% to $0.77, Revenue Hits $93.5M

Ituran (ITRN) Q4 EPS Jumps 10% to $0.77, Revenue Hits $93.5M

Ituran reports Q4 EPS of $0.77, up 10% year-over-year, with revenue reaching $93.5 million and net income of $15.3 million.

Toro (TTC) Crushes Q1 Earnings Expectations with $0.74 EPS, 14% Beat on $1.04B Revenue

Toro posts Q1 adjusted EPS of $0.74, beating estimates by 14.2%, with revenue climbing 4.2% year-over-year to $1.04 billion.

Tango Therapeutics (TNGX) Q4 Loss Narrows to $0.29/Share vs $0.33 Estimate; Shares Surge 23%

Tango Therapeutics posts narrower-than-expected Q4 loss of $0.29/share vs $0.33 estimate; shares jump 23% on the biotech's results.

Alight Faces $3.1B Goodwill Hit, Bets on AI and Operational Overhaul for 2026

Alight, Inc. (NYSE: ALIT), a provider of benefits administration and cloud-based human capital solutions with a market capitalization of approximately…

SiriusPoint Strengthens Specialty Footprint, Posts 13th Consecutive Underwriting Profit

SiriusPoint Ltd (NYSE: SPNT), a Bermuda-based specialty insurer and reinsurer, reported record full-year 2025 results, underscoring its strategic repositioning toward…

Air France-KLM Delivers Record 2025 Profit on Premium Growth and Fleet Modernization

Air France‑KLM S.A. (Euronext: AF) Market Cap ~€3.1 billion — Europe’s integrated airline group combining Air France and KLM Royal Dutch…

Rivian Stock (RIVN) Drops 5.2% as Investors Take Profits After 27% Post-Earnings Rally

Rivian shares drop 5.2% as investors lock in profits following last week's 27% post-earnings surge, with volume signaling technical consolidation.

Why Is ACN Stock Falling Today? Shares Plunge 21% Below Key Average Ahead of Earnings

ACN extends monthlong selloff, dropping 5.5% to $212.25 with no clear catalyst as shares trade 21% below 200-day average ahead…

BKNG Stock Plunges 7.65% to $3,925.75 Despite Beating Q4 Earnings Estimates

BKNG plunges 7.65% to $3,925.75 despite beating Q4 EPS estimates by 0.27%, extending losses to 25.8% from January highs on…

ASIX Earnings: AdvanSix Reports Q4 Adj. EPS of $0.03; Sales up 9% year-over-year

AdvanSix crashes 80% below EPS estimates at $0.08 vs $0.40 consensus as chemical demand weakness deepens and margins turn negative.